Skip to main content

Table 1 Vaccine recipient study groups

From: MAIT cell compartment characteristics are associated with the immune response magnitude to the BNT162b2 mRNA anti-SARS-CoV-2 vaccine

Group

HD

PLWH

PID

n

42

42

24

Sex, n (%)

 Men

19 (45.3%)

23 (54.7%)

13 (54.2%)

 Women

23 (54.7%)

19 (45.3%)

11 (45.8%)

Age years, n (%)

 18–39

16 (38.1%)

4 (9.5%)

9 (37.5%)

 40–59

12 (28.6%)

24 (57.2%)

10 (41.7%)

 > 60

14 (33.3%)

14 (33.3%)

5 (20.8%)

Immunosuppressive drugs, n (%)

 Corticosteroids

0

0

5 (19.2%)

 Others

0

0

5 (20.8%)

Other characteristics, n (%)

 

CD4 count (cells/μL)

31 (73.8%) > 300

11 (26.2%) < 300

7 (29.2%) CVID

1 (4.1%) XLA

4 (16.7%) Monogenic diseases

8 (33.3%) ICL

4 (16.7%) Other with expected normal response

  1. HD healthy donor, PLWH people living with HIV-1 infection on stable antiretroviral treatment, ICL idiopathic CD4 lymphocytopenia, PID primary immunodeficiency, CVID common variable immunodeficiency, XLA X-linked agammaglobulinemia, n number of individuals